{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:16:10Z","timestamp":1792498570106,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03592-y","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T14:26:49Z","timestamp":1734013609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of clinical and subclinical renal damage in Psoriasis"],"prefix":"10.1007","volume":"317","author":[{"given":"Belgin","family":"Kucukyangoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mualla","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4766-7454","authenticated-orcid":false,"given":"Mustafa","family":"Kucukyangoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guler","family":"Bugdayci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Metin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"3592_CR1","doi-asserted-by":"crossref","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis Pathogenesis and Treatment. Int J Mol Sci 20","DOI":"10.3390\/ijms20061475"},{"key":"3592_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386:983\u2013994","journal-title":"Lancet"},{"key":"3592_CR3","first-page":"112","volume":"17","author":"M \u00d6zden","year":"2007","unstructured":"\u00d6zden M, Tekin N (2007) Psoriasis patogenezinde yenilikler. T Klin J Dermatol 17:112\u2013119","journal-title":"T Klin J Dermatol"},{"key":"3592_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.11.001","volume":"32","author":"I Grozdev","year":"2014","unstructured":"Grozdev I, Korman N, Tsankov N (2014) Psoriasis as a systemic disease. Clin Dermatol 32:343\u2013350","journal-title":"Clin Dermatol"},{"key":"3592_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","volume":"33","author":"C Ryan","year":"2015","unstructured":"Ryan C, Kirby B (2015) Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin 33:41\u201355","journal-title":"Dermatol Clin"},{"key":"3592_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","volume":"90","author":"F Oliveira Mde","year":"2015","unstructured":"Oliveira Mde F, Rocha Bde O, Duarte GV (2015) Psoriasis: classical and emerging comorbidities. Bras Dermatol 90:9\u201320","journal-title":"Bras Dermatol"},{"key":"3592_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","volume":"50","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert P, Raksasuk S (2018) Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 50:1277\u20131283","journal-title":"Int Urol Nephrol"},{"key":"3592_CR8","doi-asserted-by":"crossref","unstructured":"Tehranchinia Z, Ghanei E, Mohammadi N, Partovi-Kia M, Rahimi H, Mozafari N (2018) No Relation between Psoriasis and Renal Abnormalities: A Case-Control Study. ScientificWorldJournal 2018:5301631","DOI":"10.1155\/2018\/5301631"},{"key":"3592_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-015-3126-4","volume":"35","author":"L Visconti","year":"2016","unstructured":"Visconti L, Leonardi G, Buemi M, Santoro D, Cernaro V, Ricciardi CA, Lacquaniti A, Coppolino G (2016) Kidney disease and psoriasis: novel evidences beyond old concepts. Clin Rheumatol 35:297\u2013302","journal-title":"Clin Rheumatol"},{"key":"3592_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM (2017) Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol 76:377\u2013390","journal-title":"J Am Acad Dermatol"},{"key":"3592_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","volume":"44","author":"E Dervisoglu","year":"2012","unstructured":"Dervisoglu E, Akturk AS, Yildiz K, Kiran R, Yilmaz A (2012) The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol 44:509\u2013514","journal-title":"Int Urol Nephrol"},{"key":"3592_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1046\/j.1468-3083.2000.00119.x","volume":"14","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski JC, Bielicka E, Wasik F, Kopec W, Szepietowski T (2000) Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14:513\u2013514","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3592_CR13","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.2174\/0929867323666160115130241","volume":"23","author":"D Krstic","year":"2016","unstructured":"Krstic D, Tomic N, Radosavljevic B, Avramovic N, Dragutinovic V, Skodric SR, Colovic M (2016) Biochemical markers of renal function. Curr Med Chem 23:2018\u20132040","journal-title":"Curr Med Chem"},{"key":"3592_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000447649","volume":"136","author":"E Castillo-Rodriguez","year":"2017","unstructured":"Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, Pizarro-S\u00e1nchez MS, Sanchez-Ni\u00f1o MD, Sanz AB, Fernandez-Fernandez B, Ortiz A (2017) Kidney Injury marker 1 and Neutrophil Gelatinase-Associated Lipocalin in chronic kidney disease. Nephron 136:263\u2013267","journal-title":"Nephron"},{"key":"3592_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","volume":"438","author":"ME Wasung","year":"2015","unstructured":"Wasung ME, Chawla LS, Madero M (2015) Biomarkers of renal function, which and when? Clin Chim Acta 438:350\u2013357","journal-title":"Clin Chim Acta"},{"key":"3592_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/0886022X.2011.649627","volume":"34","author":"D Sun","year":"2012","unstructured":"Sun D, Zhao X, Meng L (2012) Relationship between urinary podocytes and kidney diseases. Ren Fail 34:403\u2013407","journal-title":"Ren Fail"},{"key":"3592_CR17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1159\/000492407","volume":"43","author":"FS Seibert","year":"2018","unstructured":"Seibert FS, Sitz M, Passfall J, Haesner M, Laschinski P, Buhl M, Bauer F, Babel N, Pagonas N, Westhoff TH (2018) Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease. Kidney Blood Press Res 43:1255\u20131262","journal-title":"Kidney Blood Press Res"},{"key":"3592_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cca.2018.09.011","volume":"487","author":"RN Moresco","year":"2018","unstructured":"Moresco RN, Bochi GV, Stein CS, De Carvalho JAM, Cembranel BM, Bollick YS (2018) Urinary kidney injury molecule-1 in renal disease. Clin Chim Acta 487:15\u201321","journal-title":"Clin Chim Acta"},{"key":"3592_CR19","doi-asserted-by":"publisher","first-page":"e1698","DOI":"10.31661\/gmj.v9i0.1698","volume":"9","author":"F Masaebi","year":"2020","unstructured":"Masaebi F, Azizmohammad Looha M, Wang Z, Zarean E, Nasiri M, Kazerouni F, Gharishvandi F, Zayeri F (2020) Evaluation of Neutrophil Gelatinase-Associated Lipocalin and Cystatin C in early diagnosis of chronic kidney disease in the absence of the Gold Standard. Galen Med J 9:e1698","journal-title":"Galen Med J"},{"key":"3592_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10157-017-1402-0","volume":"21","author":"H Moriya","year":"2017","unstructured":"Moriya H, Mochida Y, Ishioka K, Oka M, Maesato K, Hidaka S, Ohtake T, Kobayashi S (2017) Plasma neutrophil gelatinase-associated lipocalin (NGAL) is an indicator of interstitial damage and a predictor of kidney function worsening of chronic kidney disease in the early stage: a pilot study. Clin Exp Nephrol 21:1053\u20131059","journal-title":"Clin Exp Nephrol"},{"key":"3592_CR21","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00467-017-3676-6","volume":"32","author":"T Hayashi","year":"2017","unstructured":"Hayashi T, Tokuriki S, Okuno T, Ohta G, Igarashi A, Ohshima Y (2017) Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury. Pediatr Nephrol 32:1891\u20131896","journal-title":"Pediatr Nephrol"},{"key":"3592_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol 182:840\u2013848","journal-title":"Br J Dermatol"},{"key":"3592_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11255-017-1692-x","volume":"49","author":"F Ren","year":"2017","unstructured":"Ren F, Zhang M, Hao L, Sang H (2017) Kidney involvement in psoriasis: a case-control study from China. Int Urol Nephrol 49:1999\u20132003","journal-title":"Int Urol Nephrol"},{"key":"3592_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH (2015) Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci 78:232\u2013238","journal-title":"J Dermatol Sci"},{"key":"3592_CR25","doi-asserted-by":"publisher","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961","journal-title":"BMJ"},{"key":"3592_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000246358","volume":"192","author":"O Kaftan","year":"1996","unstructured":"Kaftan O, Kaftan B, Toppare MF, Ek\u015fio\u011flu M (1996) Renal involvement in psoriasis. Dermatology 192:189\u2013190","journal-title":"Dermatology"},{"key":"3592_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"E Lee","year":"2019","unstructured":"Lee E, Han JH, Bang CH, Yoo SA, Do Han K, Kim H-N, Park YM, Lee JY, Lee JH (2019) Risk of end-stage renal disease in psoriatic patients: real-World Data from a nationwide population-based cohort study. Sci Rep 9:1\u20136","journal-title":"Sci Rep"},{"key":"3592_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar R, Shin D, Neimann A, Troxel A, Gelfand J (2010) Cause-specific mortality in patients with severe psoriasis: a population\u2010based cohort study in the UK. Br J Dermatol 163:586\u2013592","journal-title":"Br J Dermatol"},{"key":"3592_CR29","first-page":"809","volume":"95","author":"A Svedbom","year":"2015","unstructured":"Svedbom A, Dal\u00e9n J, Mamolo C, Cappelleri JC, Mallbris L, Petersson IF, St\u00e5hle M (2015) Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study. Acta Derm Venereol 95:809\u2013815","journal-title":"Acta Derm Venereol"},{"key":"3592_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dsi.2017.02.004","volume":"35","author":"S Yu","year":"2017","unstructured":"Yu S, Tu H-P, Yu C-L, Lee C-H, Hong C-H (2017) Is psoriasis an independent risk factor of renal disease? A nationwide retrospective cohort study from 1996 to 2010. Dermatologica Sinica 35:78\u201384","journal-title":"Dermatologica Sinica"},{"key":"3592_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1159\/000522228","volume":"238","author":"R Friedland","year":"2022","unstructured":"Friedland R, Kridin K, Cohen AD, Landau D, Ben-Amitai D (2022) Psoriasis and Renal disorders: a large-Scale Population-based study in children and adults. Dermatology 238:904\u2013909","journal-title":"Dermatology"},{"key":"3592_CR32","doi-asserted-by":"crossref","unstructured":"Rysz J, Gluba-Brz\u00f3zka A, Franczyk B, Jab\u0142onowski Z, Cia\u0142kowska-Rysz A (2017) Novel biomarkers in the diagnosis of chronic kidney Disease and the prediction of its outcome. Int J Mol Sci 18","DOI":"10.3390\/ijms18081702"},{"key":"3592_CR33","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","volume":"55","author":"M Hara","year":"2012","unstructured":"Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Yan K (2012) Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia 55:2913\u20132919","journal-title":"Diabetologia"},{"key":"3592_CR34","unstructured":"Kocaba\u015f RN, Ba\u015fol G (2006) Proteinuria and Its Laboratory Assesment. Turk Klinik Biyokimya Dergisi Cilt4\/Say\u0131 3:133\u2013145"},{"key":"3592_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40200-015-0131-8","volume":"14","author":"SA Ahmed","year":"2015","unstructured":"Ahmed SA, Hamed MA (2015) Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patients. J Diabetes Metab Disord 14:6","journal-title":"J Diabetes Metab Disord"},{"key":"3592_CR36","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1093\/ndt\/gfr023","volume":"26","author":"PC Xu","year":"2011","unstructured":"Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH (2011) Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transpl 26:3229\u20133236","journal-title":"Nephrol Dial Transpl"},{"key":"3592_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clim.2007.01.010","volume":"123","author":"H Ding","year":"2007","unstructured":"Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W (2007) Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 123:227\u2013234","journal-title":"Clin Immunol"},{"key":"3592_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000209379","volume":"32","author":"D Bolignano","year":"2009","unstructured":"Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M (2009) Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 32:91\u201398","journal-title":"Kidney Blood Press Res"},{"key":"3592_CR39","first-page":"115","volume":"6","author":"Y Palacios de Franco","year":"2014","unstructured":"Palacios de Franco Y, Velazquez K, Segovia N, Acosta C, Yanosky D, Franco Palacios YV, Ramos A, Franco Palacios CR (2014) Urinary podocalyxin as a marker of preeclampsia in a hispanic population. Int J Physiol Pathophysiol Pharmacol 6:115\u2013124","journal-title":"Int J Physiol Pathophysiol Pharmacol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03592-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:03:53Z","timestamp":1734015833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3592"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03592-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Bolu Abant \u0130zzet Baysal University Faculty of Medicine Ethic Committee with decision dated 2021 and numbered 2021\/03. This study was performed in accordance with the principles of the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Oral and written informed consents were obtained from all patients before enrollment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}],"article-number":"104"}}